Tesetaxel for Previously Treated Patients With Bladder Cancer

Clinical trial NCT01215877 · UNKNOWN

Trial details

NCT number: NCT01215877
Sponsor: Genta Incorporated
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Transitional Cell

Start date: 2010-09-01
Primary completion: 2012-09-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.